BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2124950)

  • 1. Evidence that weak promotion of carcinogen-initiated cells prevents their progression to malignancy.
    Reddy AL; Fialkow PJ
    Carcinogenesis; 1990 Dec; 11(12):2123-6. PubMed ID: 2124950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor progression in Sencar mouse skin as a function of initiator dose and promoter dose, duration, and type.
    Ewing MW; Conti CJ; Kruszewski FH; Slaga TJ; DiGiovanni J
    Cancer Res; 1988 Dec; 48(24 Pt 1):7048-54. PubMed ID: 3142681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of retinoic acid and 7,8-benzoflavone on the induction of mouse skin tumors by the complete carcinogenesis process and by the initiation-promotion regimen.
    Verma AK; Conrad EA; Boutwell RK
    Cancer Res; 1982 Sep; 42(9):3519-25. PubMed ID: 6286109
    [No Abstract]   [Full Text] [Related]  

  • 4. A course of very small doses of DMBA, each of them allegedly with no promoting potency, acts with clear synergistic effect as a strong promoter of DMBA-initiated mouse skin carcinogenesis. A comparison of the tumorigenic and carcinogenic effects of DMBA (7,12-dimethylbenz-alpha-anthracene) and TPA (12-O-tetradecanoyl-phorbol-13-acetate) used as initiators and promoters in classical two-stage experimental protocols.
    Iversen OH
    APMIS Suppl; 1994; 41():1-38. PubMed ID: 7946481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of skin tumor promotion and progression by chrysarobin in SENCAR mice.
    Kruszewski FH; Conti CJ; DiGiovanni J
    Cancer Res; 1987 Jul; 47(14):3783-90. PubMed ID: 3109733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor progression of murine epidermal cells after treatment in vitro with 12-O-tetradecanoylphorbol-13-acetate or retinoic acid.
    Kulesz-Martin MF; Blumenson LE; Manly KF; Siracký J; East CJ
    Cancer Res; 1991 Sep; 51(17):4701-6. PubMed ID: 1908351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential studies of skin tumorigenesis in phosphoglycerate kinase mosaic mice: effect of resumption of promotion on regressed papillomas.
    Reddy AL; Caldwell M; Fialkow PJ
    Cancer Res; 1987 Apr; 47(7):1947-51. PubMed ID: 3102053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequential studies of skin tumorigenesis in PGK mosaic mice: the effect of repeated exposure to a carcinogen on regressed mouse skin papillomas.
    Reddy AL; Fialkow PJ
    Carcinogenesis; 1987 Oct; 8(10):1455-9. PubMed ID: 3115615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperthermia and phorbol ester tumor promotion in mouse skin.
    Mitchel RE; Morrison DP; Gragtmans NJ; Jevcak JJ
    Carcinogenesis; 1986 Sep; 7(9):1505-10. PubMed ID: 3091284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Only a subset of 12-O-tetradecanoylphorbol-13-acetate-promoted mouse skin papillomas are promotable by benzoyl peroxide.
    Mancuso M; Pazzaglia S; Tanori M; Rebessi S; Di Majo V; Covelli V; Saran A
    Mutat Res; 2004 Apr; 548(1-2):35-45. PubMed ID: 15063134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of 7-bromomethylbenz[a]anthracene-promoted mouse skin tumor formation by retinoic acid and dexamethasone.
    Verma AK; Garcia CT; Ashendel CL; Boutwell RK
    Cancer Res; 1983 Jul; 43(7):3045-9. PubMed ID: 6406052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Further characterization of skin tumor promotion and progression by mezerein in SENCAR mice.
    Ewing MW; Conti CJ; Phillips JL; Slaga TJ; DiGiovanni J
    J Natl Cancer Inst; 1989 May; 81(9):676-82. PubMed ID: 2496233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of a hyperthermia treatment on chemically induced tumor initiation and progression in mouse skin.
    Mitchel RE; Morrison DP; Gragtmans NJ
    Carcinogenesis; 1988 Mar; 9(3):379-85. PubMed ID: 3125992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence that mirex promotes a unique population of epidermal cells that cannot be distinguished by their mutant Ha-ras genotype.
    Kim TW; Porter KL; Foley JF; Maronpot RR; Smart RC
    Mol Carcinog; 1997 Sep; 20(1):115-24. PubMed ID: 9328442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of papillomas with a high probability of conversion to malignancy.
    Hennings H; Shores R; Mitchell P; Spangler EF; Yuspa SH
    Carcinogenesis; 1985 Nov; 6(11):1607-10. PubMed ID: 2414025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary grape seed proanthocyanidins inhibit 12-O-tetradecanoyl phorbol-13-acetate-caused skin tumor promotion in 7,12-dimethylbenz[a]anthracene-initiated mouse skin, which is associated with the inhibition of inflammatory responses.
    Meeran SM; Vaid M; Punathil T; Katiyar SK
    Carcinogenesis; 2009 Mar; 30(3):520-8. PubMed ID: 19158151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of dose of initiator on two-stage skin carcinogenesis in BALB/c mice with cellular mosaicism.
    Reddy AL; Fialkow PJ
    Carcinogenesis; 1988 May; 9(5):751-4. PubMed ID: 3130203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the mechanism of skin tumor promotion: evidence for several stages in promotion.
    Slaga TJ; Fischer SM; Nelson K; Gleason GL
    Proc Natl Acad Sci U S A; 1980 Jun; 77(6):3659-63. PubMed ID: 6774342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic alterations cooperate with v-Ha-ras to accelerate multistage carcinogenesis in TG.AC transgenic mouse skin.
    Owens DM; Spalding JW; Tennant RW; Smart RC
    Cancer Res; 1995 Jul; 55(14):3171-8. PubMed ID: 7606738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical retinoic acid reduces skin papilloma formation but resistant papillomas are at high risk for malignant conversion.
    Tennenbaum T; Lowry D; Darwiche N; Morgan DL; Gartsbein M; Hansen L; De Luca LM; Hennings H; Yuspa SH
    Cancer Res; 1998 Apr; 58(7):1435-43. PubMed ID: 9537245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.